{"id":"fenpentadiol","rwe":[],"tags":[{"label":"fenpentadiol","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"tredum","offLabel":[],"synonyms":["fenpentadiol","fentredum","tredum"],"timeline":[],"approvals":[],"brandName":"Tredum","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"fenpentadiol","explanation":"Imagine your brain is a city with many different streets and intersections. Neurotransmitters are like the traffic signals that help different parts of the city communicate with each other. Fenpentadiol is believed to affect the way these traffic signals work, which can influence how different parts of the brain interact and respond to different stimuli.","oneSentence":"Fenpentadiol is thought to work by modulating the activity of certain neurotransmitters in the brain.","technicalDetail":"Fenpentadiol is a non-selective dopamine receptor antagonist, which means it can bind to and block multiple types of dopamine receptors in the brain, potentially influencing a range of physiological and psychological processes."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1158","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FENPENTADIOL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:15:37.603517","biosimilars":[],"competitors":[],"genericName":"fenpentadiol","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"BLO7300903","CHEBI":"CHEBI:134940","INN_ID":"2006","UMLSCUI":"C0060188","ChEMBL_ID":"CHEMBL2106273","PUBCHEM_CID":"85896","MESH_SUPPLEMENTAL_RECORD_UI":"C004997"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":10,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tredum, also known as fenpentadiol, is a small molecule drug of the fenpentadiol class. Its exact target and mechanism of action are unknown, but it is believed to work by interacting with certain biological pathways. Tredum's commercial status and approved indications are not publicly available. As a result, its safety profile and pharmacokinetic properties, including half-life and bioavailability, are also unknown. Further research is needed to fully understand this medication.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}